Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Thrombosis Research|November 1, 1989
Determination of plasminogen activator inhibitor (PAI) activity of human plasma after dilution in a PAI-depleted plasmaG Contant, J L MartinoliThrombosis Research|July 15, 1983
Heparin inactivation during blood storage: its prevention by blood collection in citric acid, theophylline, adenosine, dipyridamole-C.T.A.D. mixtureG Contant, M Gouault-Heilmann, J L MartinoliFEMS Microbiology Letters|January 27, 1999
A new gel tube method for the direct detection, identification and susceptibility testing of bacteria in clinical samplesS Langlet, F Beaupère, G Contant, et al.Annales De Biologie Clinique|April 22, 1999
[A chromogenic method for rapid identification of Staphylococcus aureus]S Langlet, G Quentin, G Contant, et al.Intensive Care Medicine|January 1, 1987
Treatment of acute pulmonary embolism by a low molecular weight heparin fraction. A preliminary studyY Huet, M Gouault-Heilmann, G Contant, et al.Annales De Biologie Clinique|January 1, 1988
[Rapid determination of protein C activity]F Nicham, J F Guichaoua, G Contant, et al.Thrombosis Research. Supplement|January 1, 1988
Measurement of tPA and tPA-PAI-1 complexes by ELISA, using monoclonal antibodies: clinical relevanceJ Amiral, V Plassart, M Grosley, et al.Thrombosis and Haemostasis|October 28, 1987
Release pattern of the vascular plasminogen activator and its inhibitor in human postvenous occlusion plasma as assessed by a spectrophotometric solid-phase fibrin-tPA activity assayE Anglés-Cano, B Boutière, D Arnoux, et al.Clinical Chemistry|August 1, 1996
Validation protocol of analytical hemostasis systems: measurement of anti-Xa activity of low-molecular-weight heparinsL Houbouyan, B Boutière, G Contant, et al.Haemostasis|January 1, 1987
Low molecular weight heparin fractions as an alternative therapy in heparin-induced thrombocytopeniaM Gouault-Heilmann, Y Huet, S Adnot, et al.Pageof 2